Dermata Therapeutics, Inc. Common Stock DRMA
$1.46
-7.01%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $10.00
- Implied Upside
- +584.9%
- Price Target Range
- $10.00 – $10.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-08-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $30 → $10 |
| 2025-05-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $6 → $3 |
| 2024-08-21 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $10 → $6 |
| 2023-03-23 | Maxim GroupAnthony Vendetti |
Maintains | Buy | $240 → $60 |
| 2021-09-21 | Brookline CapitalKumaraguru Raja |
Initiates coverage on | Buy | $3360 |
| 2021-09-14 | Maxim GroupAnthony Vendetti |
Initiates coverage on | Buy | $2160 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1.46
- Market Cap
- $5.87 million
- 52-Week Range
- $0.95 – $8.00
- Average Volume
- 1.44 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.